SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Pauli Ronald

(Last)

(First)

(Middle)

C/O SAGENT PHARMACEUTICALS, INC.

1901 NORTH ROSELLE ROAD, SUITE 700

(Street)

SCHAUMBURG

60195

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
04/19/2011

3. Issuer Name and Ticker or Trading Symbol
Sagent Holding Co. [ SGNT ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
No non-derivative securities beneficially owned	0	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option to Buy	⁽¹⁾	04/05/2017	Common Stock	10,844	$0.78	D
Stock Option to Buy	⁽²⁾	12/11/2019	Common Stock	15,310	$4.31	D
Stock Option to Buy	⁽³⁾	07/23/2020	Common Stock	15,310	$4.31	D
Stock Option to Buy	⁽⁴⁾	08/15/2018	Common Stock	19,138	$4.23	D
Stock Option to Buy	⁽⁵⁾	08/15/2018	Common Stock	25,517	$4.23	D
Stock Option to Buy	⁽⁶⁾	12/02/2020	Common Stock	27,431	$11.6	D

Explanation of Responses:

1. Stock option granted on April 5, 2007 and fully vested as of April 2, 2011.

2. Stock option granted on December 11, 2009 and vests 25% per year over four years.

3. Stock option granted on July 23, 2010 and vests 25% per year over four years.

4. Stock option granted on August 15, 2008 and vests upon the achievement of certain milestones.

5. Stock option granted on August 15, 2008 and vests 25% per year over four years.

6. Stock option granted on December 2, 2010 and vests 25% per year over four years.

	/s/ Ronald Pauli	04/19/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.